Brandon Couillard
Stock Analyst at Wells Fargo
(4.59)
# 245
Out of 5,042 analysts
147
Total ratings
64.89%
Success rate
17.66%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Overweight | $565 → $635 | $572.50 | +10.92% | 7 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $205 → $230 | $223.01 | +3.13% | 4 | Oct 23, 2025 | |
| NTRA Natera | Initiates: Equal-Weight | $175 | $192.51 | -9.10% | 1 | Sep 22, 2025 | |
| GH Guardant Health | Initiates: Overweight | $72 | $72.15 | -0.21% | 1 | Sep 22, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $140 → $150 | $148.03 | +1.33% | 24 | Sep 15, 2025 | |
| CDNA CareDx | Maintains: Equal-Weight | $19 → $14 | $14.97 | -6.48% | 3 | Aug 8, 2025 | |
| MLAB Mesa Laboratories | Upgrades: Equal-Weight | $100 → $67 | $79.16 | -15.36% | 3 | Aug 8, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $330 → $315 | $359.50 | -12.38% | 5 | Aug 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $60 → $50 | $39.00 | +28.21% | 5 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Overweight | $19 → $16 | $15.40 | +3.90% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $265 | $339.75 | -22.00% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $265 | $343.83 | -22.93% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $175 | $166.33 | +5.21% | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $95 | $128.87 | -26.28% | 4 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $59 | $65.91 | -10.48% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $6 | $8.15 | -26.38% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,125 → $1,200 | $1,434.32 | -16.34% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $98.89 | +3.14% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $135.21 | +92.29% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $63.84 | +25.31% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $64.64 | +31.50% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $3.41 | +193.26% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $20.36 | +12.97% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.22 | +965.57% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.96 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.70 | +308.16% | 2 | Oct 13, 2017 |
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Overweight
Price Target: $565 → $635
Current: $572.50
Upside: +10.92%
Danaher
Oct 23, 2025
Maintains: Equal-Weight
Price Target: $205 → $230
Current: $223.01
Upside: +3.13%
Natera
Sep 22, 2025
Initiates: Equal-Weight
Price Target: $175
Current: $192.51
Upside: -9.10%
Guardant Health
Sep 22, 2025
Initiates: Overweight
Price Target: $72
Current: $72.15
Upside: -0.21%
Agilent Technologies
Sep 15, 2025
Maintains: Overweight
Price Target: $140 → $150
Current: $148.03
Upside: +1.33%
CareDx
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $14.97
Upside: -6.48%
Mesa Laboratories
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $79.16
Upside: -15.36%
Waters
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $330 → $315
Current: $359.50
Upside: -12.38%
Bruker
Aug 5, 2025
Maintains: Overweight
Price Target: $60 → $50
Current: $39.00
Upside: +28.21%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $15.40
Upside: +3.90%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $339.75
Upside: -22.00%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $245 → $265
Current: $343.83
Upside: -22.93%
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $166.33
Upside: +5.21%
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $78 → $95
Current: $128.87
Upside: -26.28%
May 30, 2025
Initiates: Overweight
Price Target: $59
Current: $65.91
Upside: -10.48%
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $8.15
Upside: -26.38%
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,434.32
Upside: -16.34%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $98.89
Upside: +3.14%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $135.21
Upside: +92.29%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $63.84
Upside: +25.31%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $64.64
Upside: +31.50%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $3.41
Upside: +193.26%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $20.36
Upside: +12.97%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.22
Upside: +965.57%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.96
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.70
Upside: +308.16%